Cargando…

HDAC2 Inhibitor Valproic Acid Increases Radiation Sensitivity of Drug-Resistant Melanoma Cells

Resistance to anticancer drugs limits the effectiveness of chemotherapy in cancers. Melanoma cell lines B16F10C and A375C (parental) and B16F10R and A375R (drug-resistant sublines) were used to test radiation sensitization potential of valproic acid (VPA), an inhibitor of Histone deacetylase2 (HDAC2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalal, Bhuvanesh Sukhlal, Pai, Vinitha Ramanath, Behera, Santosh Kumar, Somashekarappa, Hiriyur Mallaiah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473314/ https://www.ncbi.nlm.nih.gov/pubmed/30909413 http://dx.doi.org/10.3390/medsci7030051

Ejemplares similares

Chemotherapy Resistance Mechanisms in Advanced Skin Cancer
por: Kalal, Bhuvanesh Sukhlal, et al.
Publicado: (2017)

Inhibition of ERK1/2 or AKT Activity Equally Enhances Radiation Sensitization in B16F10 Cells
por: Kalal, Bhuvanesh Sukhlal, et al.
Publicado: (2018)

Cytotoxic, DNA Cleavage and Pharmacokinetic Parameter Study of Substituted Novel Furan C-2 Quinoline Coupled 1, 2, 4-Triazole and Its Analogs
por: Anantacharya, Rajpurohit, et al.
Publicado: (2018)

Cytotoxic, DNA Cleavage and Pharmacokinetic Parameter Study of Substituted Novel Furan C-2 Quinoline Coupled 1, 2, 4-Triazole and Its Analogs
por: Anantacharya, Rajpurohit, et al.
Publicado: (2018)

Antioxidative and radioprotective potential of rutin and quercetin in Swiss albino mice exposed to gamma radiation
por: Patil, Shrikant L., et al.
Publicado: (2013)

Oxidative stress in cervical cancer and its response to chemoradiation
por: Shah, Saiqa, et al.
Publicado: (2019)

Histone Deacetylases (HDAC) Inhibitor—Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor
por: Drzewiecka, Małgorzata, et al.
Publicado: (2023)

Diabetogenic effect of gluten in Wistar albino rats: a preliminary preclinical screening
por: Shetty, Robin, et al.
Publicado: (2020)

Prevalence of respiratory syncytial virus infection among children hospitalized with acute lower respiratory tract infections in Southern India
por: Kini, Sandesh, et al.
Publicado: (2019)

Structural and Optical Modifications in the BaO-ZnO-LiF-B(2)O(3)-Yb(2)O(3) Glass System after γ-Irradiation
por: Prabhu, Nimitha S., et al.
Publicado: (2021)

HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
por: Segura-Pacheco, Blanca, et al.
Publicado: (2007)

Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors
por: Zhang, Zhihua, et al.
Publicado: (2013)

Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
por: Pitt, Bertram, et al.
Publicado: (2021)

Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3
por: Leng, Yan, et al.
Publicado: (2016)

Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro
por: Makarević, Jasmina, et al.
Publicado: (2019)

HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice
por: Scholz, Beatrix, et al.
Publicado: (2019)

Improving Insulin Sensitivity With HDAC Inhibitor
por: Ye, Jianping
Publicado: (2013)

HDAC inhibitors enhance the immunotherapy response of melanoma cells
por: Booth, Laurence, et al.
Publicado: (2017)

Valproic Acid as a Potential Inhibitor of Plasmodium falciparum Histone Deacetylase 1 (PfHDAC1): An in Silico Approach
por: Elbadawi, Mohamed A. Abdallah, et al.
Publicado: (2015)

HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction
por: Tian, Shuo, et al.
Publicado: (2018)

The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation
por: Blaauboer, Amber, et al.
Publicado: (2022)

Dihydrocoumarin, an HDAC Inhibitor, Increases DNA Damage Sensitivity by Inhibiting Rad52
por: Chen, Chin-Chuan, et al.
Publicado: (2017)

Exposure to valproic acid (VPA) reproduces hdac1 loss of function phenotypes in zebrafish
por: Jones, Alec A., et al.
Publicado: (2023)

Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo
por: Juengel, Eva, et al.
Publicado: (2013)

In Vivo Screening Using Transgenic Zebrafish Embryos Reveals New Effects of HDAC Inhibitors Trichostatin A and Valproic Acid on Organogenesis
por: Li, Ling, et al.
Publicado: (2016)

HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma
por: Sriramareddy, Sathya Neelature, et al.
Publicado: (2022)

HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma
por: Souri, Zahra, et al.
Publicado: (2020)

YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor
por: Dong, Sheng, et al.
Publicado: (2017)

PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation
por: Jonuscheit, Stephanie, et al.
Publicado: (2021)

E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors
por: Decourtye-Espiard, Lyvianne, et al.
Publicado: (2021)

The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3
por: Ni, Lulu, et al.
Publicado: (2017)

Combining HDAC and MEK Inhibitors with Radiation against Glioblastoma-Derived Spheres
por: Essien, Eno I., et al.
Publicado: (2022)

Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
por: Liu, Jiaqi, et al.
Publicado: (2016)

Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma
por: Khalil, Mohamed Ashraf, et al.
Publicado: (2016)

HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis
por: Balliu, Manjola, et al.
Publicado: (2015)

HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases
por: Yoon, Somy, et al.
Publicado: (2016)

Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells
por: Thotala, Dinesh, et al.
Publicado: (2015)

Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis
por: Murahari, Sridhar, et al.
Publicado: (2017)

Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
por: Eyre, Toby A.
Publicado: (2018)

IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat
por: Sears, Thomas K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_npgm176k3ksosfkrkfsf50q1pb